MedPath

Efficacy of Arjuna ghana vati and Sarpagandha ghana vati in Hypertensio

Phase 4
Not yet recruiting
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2022/07/043858
Lead Sponsor
Chaudhary Brahm Prakash Ayurved Charak Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with Stage 1 Hypertension according to JNC 8th Criteria

2.Patients presenting with symptoms of hypertension and comes under pre hypertension

3.Patients freshly diagnosed with hypertension

4.Patients who have been already diagnosed with hypertension and are not under regular medications for minimum of two months and comes under stage 1 hypertension

5.Patients with isolated systolic hypertension and

Essential hypertension

Exclusion Criteria

1.Patients below 18 years of age and above 60 years of age

2.Patient not willing for trial

3.Patients having systolic blood pressure greater than 160 mm hg and diastolic blood pressure greater than 100 mm hg

4.Complicated hypertensive cases like Nephropathy and left ventricular hypertrophy, Heart block congestive heart failure, coronary artery disease and retinopathy

5.Patients suffering with Diabetes mellitus

6.Patients with isolated diastolic hypertension,

Accelerated and malignant hypertension

7.Patient taking steroids, oral contraceptive pills. estrogen replacement therapy or NSAID group of drugs

8.Patient with severe other illness hepatic or renal failure

9.Secondary hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.